Health officials are preparing for mpox to hit the UK, after the World Health Organisation (WHO) declared a global health emergency over a new strain spreading rapidly in Africa.
The UK Health Security Agency (UKHSA) said there are currently no cases of the virus here and the risk to the British population ‘is currently considered low’.
But deputy director Dr Meera Chand added: ‘Planning is under way to prepare for any cases that we might see in the UK.
‘This includes ensuring that clinicians are aware and able to recognise cases promptly, that rapid testing is available, and that protocols are developed for the safe clinical care of people who have the infection and the prevention of onward transmission.’
Here’s everything you need to know about the mpox outbreak.
What is mpox?
Mpox – also known as monkeypox – was first identified by scientists in 1958 when there were outbreaks of a ‘pox-like’ disease in monkeys.
Until recently, most human cases were seen in people in central and West Africa who had close contact with infected animals.
In 2022, the virus was confirmed to spread via sex for the first time and triggered outbreaks in more than 70 countries across the world that had not previously reported mpox.
What are the symptoms of mpox and how is it spread?
Mpox belongs to the same family of viruses as smallpox but causes milder symptoms like fever, chills and body aches.
People with more serious cases can develop lesions on the face, hands, chest and genitals.
Symptoms include a high temperature, headache, muscle aches, backache, swollen glands, exhaustion, joint pain and a rash.
While they are usually mild, the viral infection can kill.
Children, pregnant women and people with weakened immune systems, such as those with HIV, are all at higher risk of complications.
Mpox is passed on through close physical contact, including during sexual contact, kissing, cuddling or holding hands.
The new offshoot has caused global alarm because it appears to spread more easily between people.
What is the new strain and what risk does it pose to the UK?
The new strain of mpox is known as clade 1b and it emerged in the Democratic Republic of the Congo (DRC) last year, according to WHO.
The disease is now rapidly spreading to neighbouring countries in Africa, mainly through sexual networks, WHO said, with one case confirmed in Europe.
Where was the first European case detected?
Swedish health officials announced that there has been one confirmed case of clade 1b on Thursday.
The country’s public health agency said a patient sought healthcare in Stockholm and is understood to have been infected during a visit to Africa.
What do UK health officials say?
Before the case in Sweden was announced, and following the declaration of clade 1b as a global emergency by the WHO, the UK Health Security Agency (UKHSA) said it was on alert for any cases of the virus.
Officials said there are currently no cases in the UK and the risk to the population is low.
However, the UK is preparing for any potential cases by ensuring clinicians are aware of mpox and able to recognise cases promptly.
Rapid testing is also being made available, while protocols are being developed for the safe care of potential patients to prevent transmission.
Why has the WHO declared a global emergency?
Mpox was first detected in humans in the DRC in 1970 and is considered endemic to countries in Central and West Africa.
However, WHO said the recent surge of cases in DRC and its spread to neighbouring countries constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations (2005) on Wednesday.
According to WHO, mpox has been reported in DRC for more than 10 years, with the number of cases increasing steadily over the period.
So far in 2024, there have been more than 17,000 cases of mpox and 517 deaths, which the WHO said exceeds last year’s total.
There have also been 100 lab-confirmed cases of clade 1b in four countries neighbouring the DRC that have not reported mpox before: Burundi, Kenya, Rwanda and Uganda.
What do the experts say?
Dr Jonas Albarnaz, a research fellow specialising in pox viruses at the Pirbright Institute, said the case of clade 1b in Sweden ‘is concerning for two main reasons’.
‘First, this is the first clade 1 mpox virus case outside Africa. This indicates that the extent of the international spread of clade 1 outbreak in DRC might be larger than we knew yesterday.
‘And second, clade 1 mpox virus is associated with a more severe disease and higher mortality rates than the clade 2 virus responsible for the international mpox outbreak in 2022.’
Michael Marks, a professor of medicine at the London School of Hygiene and Tropical Medicine (LSHTM), said: ‘It’s clear that this is the largest outbreak of mpox reported from the region.
‘It’s also the largest of the clade 1 mpox virus, which has traditionally been associated with a higher case fatality rate than clade 2, which caused the large global outbreak in 2022.’
How did the UK deal with the last outbreak?
Before the spring of 2022, cases in the UK were usually associated with travel to or from West or Central Africa.
However, in May of that year sustained transmission of the virus was identified in the UK, leading to a large outbreak mostly in men who are gay, bisexual or have sex with other men.
A vaccination programme was launched in the UK in the summer of 2022 and closed the following July.
According to the UKHSA, there were 3,732 confirmed and highly probable mpox cases reported in the UK up to December 31, 2022. In 2023 and up to July 31 this year, 286 cases were reported.
Of these, 269 were in England – with 116 patients presumed to have caught the virus in the UK and 82 outside of the country.
Is there an mpox vaccine?
There are three vaccines which protect against mpox, each of which originated as vaccines against smallpox.
But people are advised to only get jabbed if they are at high risk of contracting it.
For those outside areas affected by the current outbreak, the risk remains very low.
Vaccines to help curb an escalating mpox outbreak in Democratic Republic of Congo and neighbouring countries may still not reach the central African country for months.
Africa CDC director general Jean Kaseya said on Tuesday there was a clear plan to secure three million doses of vaccine this year, without elaborating further.
But sources involved in planning a vaccination roll-out in Congo said only 65,000 doses were likely to be available in the short-term, and campaigns were unlikely to begin before October at the earliest.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE : Experts reveal high-fat diets have an ‘extraordinary’ effect on anxiety
MORE : UK ‘should’ve been more prepared for mpox’ amid warning it ‘may be here’
MORE : Why do people get bitten by insects more than others?
Get your need-to-know
latest news, feel-good stories, analysis and more
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.